Co-Founder, Chairman & Chief Executive Officer

Zhiyu Yan is seasoned pharmaceutical executive in China. He co-founded Sperogenix Therapeutics and is Chairman of BoD and Chief Executive Officer of Sperogenix and its group companies. Zhiyu received his medical degree in Shanghai Medical University in 1993, and afterwards practiced in the cardiology department of Shanghai Zhongshan Hospital. After joining the pharmaceutical industry 28 years ago, Zhiyu worked in the Chinese affiliates of Glaxo, Amgen and Roche in the field of clinical development and strategic marketing. Since 2001, Zhiyu has become senior executives in the Chinese affiliates of Merck KGaA, Sandoz and Actelion. His management scope has covered clinical & regulatory development, portfolio & strategy, business development, sales and marketing, as well as commercial channel management and operations. Zhiyu was the first General Manager of Actelion China since the company started its business in China in 2009. In 2015 Zhiyu joined Sanofi Pasteur, which is the Vaccine unit of Sanofi group as Executive Director headed its China business operations.